disease

Documents about disease

• Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease#8233HAL (France)
• Metformin in Parkinson Disease#126051ClinicalTrials.gov
• Projections of Global Mortality and Burden of Disease from 2002 to 2030#6896OpenAlex
• Clinical diagnosis of Alzheimer's disease#6815OpenAlex
• Hyperoxia During Pulmonary Rehabilitation in Chronic Lung Disease - Does it Matter?#125996ClinicalTrials.gov
• A contribution to the mathematical theory of epidemics#6881OpenAlex
• Neurobiologic Advances from the Brain Disease Model of Addiction#10565OpenAlex
• Current potential biomarkers for Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis: review of literature#4659Europe PMC
• MDS clinical diagnostic criteria for Parkinson's disease#7393OpenAlex
• Vector-borne disease surveillance and control resource needs in Colorado public health organizations#120215PLOS
• Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016#10463OpenAlex
• Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016#10484OpenAlex
• NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease#7359OpenAlex
• Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease#123660ClinicalTrials.gov
• Health System Readiness for Disease-Modifying Therapies for Alzheimer Disease: Health Systems#1936NCBI Bookshelf
• Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019#6832OpenAlex
• Neglected kingdoms: the gut virome, mycobiome and their role in inflammatory bowel disease#4491Europe PMC
• Home visits: a strategy to improve newborn survival - Authors' reply#6822OpenAlex
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease#6844OpenAlex
• Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association#7091OpenAlex
• Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association#7094OpenAlex
• Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019#7137OpenAlex
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease#6831OpenAlex
• Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease#7394OpenAlex
• Prevalence and impact of hyponatremia in chronic obstructive pulmonary disease. A systematic review and meta-analysis.#9896PubMed
• The Environment and Disease: Association or Causation?#7399OpenAlex
• The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease#125963ClinicalTrials.gov
• The burden of peptic ulcer disease in China, 1990-2021: update from the GBD 2021 study#5123Europe PMC
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.#6922OpenAlex
• German disease.#115186PhilArchive
• Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015#7231OpenAlex
• Potential Eligibility and Estimated Preventable Cardiovascular Disease Events From Inclisiran Treatment in the United States#67758ClinicalTrials.gov
• Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease#123434ClinicalTrials.gov
• A Review On Shatkriyakala (Disease Progression) In Veiw Of Surgical Disease Management#124207Zenodo (CERN)
• The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease#126049ClinicalTrials.gov
• Condensin complexes: from chromatin organization to disease#4640Europe PMC
• A new coronavirus associated with human respiratory disease in China#6798OpenAlex
• Oscillating Positive Expiratory Pressure Devices and Acute Exacerbation of Chronic Obstructive Pulmonary Disease#127624ClinicalTrials.gov
• Metformin Use in Chronic Kidney Disease: The CKD-Met Study#127824ClinicalTrials.gov
• Use of administrative data for evaluating trends in medically-attended Lyme disease, Manitoba, Canada, 2010–2021#10243PLOS
• Beyond silos: Drivers and barriers to intersectoral collaboration in zoonotic disease surveillance and response in the Greater Accra Metropolitan Area, Ghana#25946PLOS
• Theiler's murine encephalomyelitis virus as the infectious agent for a virally induced mouse model of Parkinson's disease#123209Europe PMC
• Evidence review for corticosteroids in meningococcal disease: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review H#2183NCBI Bookshelf
• Markers of Inflammation and Cardiovascular Disease#6547OpenAlex
• A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)#28528ClinicalTrials.gov
• Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification#121485ClinicalTrials.gov
• Evaluation of the Lung Capillary Blood Volume in Children With Sickle Cell Disease#123589ClinicalTrials.gov
• Quality of Life Assessment of Children With Congenital Heart Disease Aged 5 to 7 Years#123615ClinicalTrials.gov
• Prevalence and Pathophysiology of Systemic Arterial Pressure Abnormalities in Childhood Sickle Cell Disease#127732ClinicalTrials.gov
• Stomach disease ITS#116283PhilArchive

Related topics